Literature DB >> 32111134

Anti-Pituitary and Anti-Hypothalamus Autoantibody Associations with Inflammation and Persistent Hypogonadotropic Hypogonadism in Men with Traumatic Brain Injury.

Sushupta M Vijapur1, Zhihui Yang2,3, David J Barton4, Leah Vaughan1, Nabil Awan1, Raj G Kumar5, Byung-Mo Oh6, Sarah L Berga7, Kevin K Wang3,4, Amy K Wagner1,8,9,10.   

Abstract

Traumatic brain injury (TBI) and can lead to persistent hypogonadotropic hypogonadism (PHH) and poor outcomes. We hypothesized that autoimmune and inflammatory mechanisms contribute to PHH pathogenesis. Men with moderate-to-severe TBI (n = 143) were compared with healthy men (n = 39). The TBI group provided blood samples 1-12 months post-injury (n = 1225). TBI and healthy control (n = 39) samples were assayed for testosterone (T) and luteinizing hormone (LH) to adjudicate PHH status. TBI samples 1-6 months post-injury and control samples were assayed for immunoglobulin M (IgM)/immunoglobulin G (IgG) anti-pituitary autoantibodies (APA) and anti-hypothalamus autoantibodies (AHA). Tissue antigen specificity for APA and AHA was confirmed via immunohistochemistry (IHC). IgM and IgG autoantibodies for glial fibrillary acid protein (GFAP) (AGA) were evaluated to gauge APA and AHA production as a generalized autoimmune response to TBI and to evaluate the specificity of APA and AHA to PHH status. An inflammatory marker panel was used to assess relationships to autoantibody profiles and PHH status. Fifty-one men with TBI (36%) had PHH. An age-related decline in T levels by both TBI and PHH status were observed. Injured men had higher APA IgM, APA IgG, AHA IgM, AHA IgG, AGA IgM, and AGA IgG than controls (p < 0.0001 all comparisons). However, only APA IgM (p = 0.03) and AHA IgM (p = 0.03) levels were lower in the PHH than in the non-PHH group in multivariate analysis. There were no differences in IgG levels by PHH status. Multiple inflammatory markers were positively correlated with IgM autoantibody production. PHH was associated with higher soluble tumor-necrosis-factor receptors I/II, (sTNFRI, sTNFRII), regulated on activation, normal T-cell expressed and secreted (RANTES) and soluble interleukin-2-receptor-alpha (sIL-2Rα) levels. Higher IgM APA, and AHA, but not AGA, in the absence of PHH may suggest a beneficial or reparative role for neuroendocrine tissue-specific IgM autoantibody production against PHH development post-TBI.

Entities:  

Keywords:  IgG autoantibody; IgM autoantibody; TBI; autoantibodies; autoimmunity; hypogonadism; hypopituitarism; inflammation

Year:  2020        PMID: 32111134      PMCID: PMC7336882          DOI: 10.1089/neu.2019.6780

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  113 in total

1.  TBI translational rehabilitation research in the 21st Century: exploring a Rehabilomics research model.

Authors:  A K Wagner
Journal:  Eur J Phys Rehabil Med       Date:  2010-12       Impact factor: 2.874

2.  Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.

Authors:  M Schubert; F Jockenhövel
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

3.  Drug effects on male sexual function.

Authors:  C G Smith
Journal:  Clin Obstet Gynecol       Date:  1982-09       Impact factor: 2.190

4.  Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.

Authors:  Raj G Kumar; Jennifer A Boles; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2015 Nov-Dec       Impact factor: 2.710

5.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation.

Authors:  Marta Bondanelli; Maria Rosaria Ambrosio; Lorenza Cavazzini; Amedeo Bertocchi; Maria Chiara Zatelli; Anna Carli; Domenico Valle; Nino Basaglia; Ettore C Degli Uberti
Journal:  J Neurotrauma       Date:  2007-11       Impact factor: 5.269

7.  Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.

Authors:  M Santarsieri; R G Kumar; P M Kochanek; S Berga; A K Wagner
Journal:  Brain Behav Immun       Date:  2014-09-16       Impact factor: 7.217

Review 8.  Toward a structure-based comprehension of the lectin pathway of complement.

Authors:  Troels R Kjaer; Steffen Thiel; Gregers R Andersen
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

9.  Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans.

Authors:  Jennifer R Hay; Victoria E Johnson; Adam M H Young; Douglas H Smith; William Stewart
Journal:  J Neuropathol Exp Neurol       Date:  2015-12       Impact factor: 3.148

Review 10.  Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation.

Authors:  Michal Schwartz; Kuti Baruch
Journal:  J Autoimmun       Date:  2014-09-08       Impact factor: 7.094

View more
  4 in total

1.  Beyond Binary: Influence of Sex and Gender on Outcome after Traumatic Brain Injury.

Authors:  Katherine R Giordano; Luisa M Rojas-Valencia; Vedanshi Bhargava; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2020-09-02       Impact factor: 5.269

2.  Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury.

Authors:  Sushupta M Vijapur; Leah E Vaughan; Nabil Awan; Dominic DiSanto; Gina P McKernan; Amy K Wagner
Journal:  Brain Behav Immun       Date:  2021-01-30       Impact factor: 19.227

3.  Early chronic systemic inflammation and associations with cognitive performance after moderate to severe TBI.

Authors:  Kristen A Milleville; Nabil Awan; Dominic Disanto; Raj G Kumar; Amy K Wagner
Journal:  Brain Behav Immun Health       Date:  2020-12-15

4.  Anti-hypothalamus autoantibodies in anorexia nervosa: a possible new mechanism in neuro-physiological derangement?

Authors:  Andrea Escelsior; Ludovica Cogorno; Samir G Sukkar; Andrea Amerio; Lorenzo M Donini; Marina Bellomo; Erika Iervasi; Mario Amore; Daniele Saverino
Journal:  Eat Weight Disord       Date:  2022-03-16       Impact factor: 3.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.